Bolt Biotherapeutics, Inc.

BOLT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$63-$69-$88-$99
Dep. & Amort.$2$2$2$1
Deferred Tax$0$0$0$3
Stock-Based Comp.$7$9$10$9
Change in WC-$8-$10-$3$21
Other Non-Cash$1-$2$3$9
Operating Cash Flow-$61-$70-$77-$57
Investing Activities
PP&E Inv.-$0-$0-$2-$2
Net Acquisitions$0$0-$60$230
Inv. Purchases-$89-$165-$181-$313
Inv. Sales/Matur.$146$236$241$84
Other Inv. Act.$0$0$60-$230
Investing Cash Flow$58$71$58-$232
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$1$259
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$52
Financing Cash Flow$0$0$1$311
Forex Effect$0$0$0$0
Net Chg. in Cash-$4$2-$18$22
Supplemental Information
Beg. Cash$13$11$29$7
End Cash$9$13$11$29
Free Cash Flow-$61-$70-$78-$59
Bolt Biotherapeutics, Inc. (BOLT) Financial Statements & Key Stats | AlphaPilot